theheartorg | Medscape ✓

@theheartorg · US, UK, Canada · joined 21 Sep 2008

theheartorg | Medscape Cardiology is your best source for cardiovascular disease news online.

43 521Followers

1 579Following

29 078Posts total

2.6KViews on collected posts

Neueste Beiträge

theheartorg | Medscape ✓@theheartorg4 Sep

SAVE THE DATE 🗓️ Join Dr. Anjali Tiku Owens as she shares actionable frameworks to optimize therapy and transition to CMIs. 🗓️ Sept 14th ⏰ 12:00pm ET 🔗 https://t.co/jgIMx6Q7Nc #Cardiology #oHCM #CME https://t.co/oRfxkl89bs 416 views · 0 likes · 0 reposts · 0 replies Open on X →

theheartorg | Medscape ✓@theheartorg4 Sep

🧠 Recurrent stroke carries a profound human burden—but prevention is evolving. Explore patient-relevant evidence for factor XIa inhibitors. 🧬, phase 3 patient profiles & their emerging risk-benefit picture ⚖️ Stay ahead of what’s next 👉 https://t.co/PjtnWlhIEA https://t.co/tlPMgU 584 views · 1 likes · 1 reposts · 0 replies Open on X →

theheartorg | Medscape ✓@theheartorg4 Sep

Lipid management remains a cornerstone of cardiovascular risk reduction. This World Heart Month, reassess treatment targets, intensify lipid-lowering therapy where indicated, and adopt comprehensive evidence-based strategies to reduce cardiovascular morbidity and mortality in htt 354 views · 0 likes · 0 reposts · 0 replies Open on X →

theheartorg | Medscape ✓@theheartorg4 Sep

🧬 Could factor XIa inhibition reshape secondary stroke prevention? Explore the science behind targeting factor XI/XIa, review the 🧪 latest trial data & identify patients who may benefit from this emerging approach. 🚀 Stay ahead of the evidence—register today! https://t.co/7STa757 663 views · 2 likes · 0 reposts · 0 replies Open on X →

theheartorg | Medscape ✓@theheartorg3 Sep

⚡ Act earlier in outpatient HF care! Recognize decompensation, personalize SC diuretic therapy, integrate wearable data, and build collaborative pathways 🤝. #HFSA2026 https://t.co/Fz3WQF7OAJ https://t.co/ja8YHQkrWP 624 views · 2 likes · 0 reposts · 0 replies Open on X →

Im Vergleich zu Konten gleicher Größe

5 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. liegt bei Reichweite und Interaktion unter vergleichbaren Konten.

Medianaufrufe584dieses Konto924Median für 10K–100K

Reichweite, %1.34%dieses Konto3.62%Median für 10K–100K

Interaktion, %0.30%dieses Konto1.52%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	584	924	0.63×
Reichweite (Aufrufe ÷ Follower)	1.34%	3.62%	0.37×
Interaktionsrate	0.30%	1.52%	0.20×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6243 Sep

6634 Sep

354

584

416

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.32%3 Sep

0.30%4 Sep

0.00%

0.34%

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes71.4%5 in total

Reposts14.3%1 in total

Bookmarks14.3%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Neueste Beiträge

Im Vergleich zu Konten gleicher Größe

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Ähnliche Konten